首页> 美国卫生研究院文献>Clinical and Developmental Immunology >Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation
【2h】

Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation

机译:前沿:免疫调节中的益生菌和粪便微生物群移植

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Probiotics are commensal or nonpathogenic microbes that confer beneficial effects on the host through several mechanisms such as competitive exclusion, antibacterial effects, and modulation of immune responses. Some probiotics have been found to regulate immune responses via immune regulatory mechanisms. T regulatory (Treg) cells, T helper cell balances, dendritic cells, macrophages, B cells, and natural killer (NK) cells can be considered as the most determinant dysregulated mediators in immunomodulatory status. Recently, fecal microbiota transplantation (FMT) has been defined as the transfer of distal gut microbial communities from a healthy individual to a patient's intestinal tract to cure some immune disorders (mainly inflammatory bowel diseases). The aim of this review was followed through the recent literature survey on immunomodulatory effects and mechanisms of probiotics and FMT and also efficacy and safety of probiotics and FMT in clinical trials and applications.
机译:益生菌是共生或非致病性微生物,它们通过竞争排斥,抗菌作用和免疫应答调节等多种机制赋予宿主有益的作用。已经发现一些益生菌通过免疫调节机制调节免疫应答。 T调节(Treg)细胞,T辅助细胞平衡,树突状细胞,巨噬细胞,B细胞和自然杀伤(NK)细胞可以被认为是免疫调节状态中最决定性的失调介体。最近,粪便微生物群移植(FMT)已被定义为将远端肠道微生物群落从健康个体转移至患者肠道以治愈某些免疫疾病(主要是炎症性肠病)。通过近期有关益生菌和FMT的免疫调节作用和机制以及益生菌和FMT在临床试验和应用中的功效和安全性的文献调查,遵循了本综述的目的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号